Pharma & Healthcare
Global Insulin Aspart 30 Injection Market Research Report 2025
- Jun 01, 25
- ID: 284395
- Pages: 86
- Figures: 87
- Views: 14
The global market for Insulin Aspart 30 Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Insulin Aspart 30 Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Insulin Aspart 30 Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Insulin Aspart 30 Injection include Novo Nordisk, Sihuan Pharmaceutical, Gan and Lee Pharmaceuticals Co., Ltd., YiChang HEC ChangJiang Pharmaceutical Co., Ltd., Tonghua Dongbao Pharmaceutical Co.,Ltd., The United Laboratories International Holdings Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Insulin Aspart 30 Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Aspart 30 Injection.
The Insulin Aspart 30 Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin Aspart 30 Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Aspart 30 Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novo Nordisk
Sihuan Pharmaceutical
Gan and Lee Pharmaceuticals Co., Ltd.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Tonghua Dongbao Pharmaceutical Co.,Ltd.
The United Laboratories International Holdings Ltd.
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Aspart 30 Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Aspart 30 Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for Insulin Aspart 30 Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Insulin Aspart 30 Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Insulin Aspart 30 Injection include Novo Nordisk, Sihuan Pharmaceutical, Gan and Lee Pharmaceuticals Co., Ltd., YiChang HEC ChangJiang Pharmaceutical Co., Ltd., Tonghua Dongbao Pharmaceutical Co.,Ltd., The United Laboratories International Holdings Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Insulin Aspart 30 Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Aspart 30 Injection.
The Insulin Aspart 30 Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin Aspart 30 Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Aspart 30 Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novo Nordisk
Sihuan Pharmaceutical
Gan and Lee Pharmaceuticals Co., Ltd.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Tonghua Dongbao Pharmaceutical Co.,Ltd.
The United Laboratories International Holdings Ltd.
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Aspart 30 Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Aspart 30 Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Insulin Aspart 30 Injection Market Overview
1.1 Product Definition
1.2 Insulin Aspart 30 Injection by Type
1.2.1 Global Insulin Aspart 30 Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Insulin Aspart 30 Injection by Application
1.3.1 Global Insulin Aspart 30 Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Insulin Aspart 30 Injection Market Size Estimates and Forecasts
1.4.1 Global Insulin Aspart 30 Injection Revenue 2020-2031
1.4.2 Global Insulin Aspart 30 Injection Sales 2020-2031
1.4.3 Global Insulin Aspart 30 Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Insulin Aspart 30 Injection Market Competition by Manufacturers
2.1 Global Insulin Aspart 30 Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Insulin Aspart 30 Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Insulin Aspart 30 Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Insulin Aspart 30 Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Aspart 30 Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Aspart 30 Injection, Product Type & Application
2.7 Global Key Manufacturers of Insulin Aspart 30 Injection, Date of Enter into This Industry
2.8 Global Insulin Aspart 30 Injection Market Competitive Situation and Trends
2.8.1 Global Insulin Aspart 30 Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Insulin Aspart 30 Injection Players Market Share by Revenue
2.8.3 Global Insulin Aspart 30 Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Aspart 30 Injection Market Scenario by Region
3.1 Global Insulin Aspart 30 Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Insulin Aspart 30 Injection Sales by Region: 2020-2031
3.2.1 Global Insulin Aspart 30 Injection Sales by Region: 2020-2025
3.2.2 Global Insulin Aspart 30 Injection Sales by Region: 2026-2031
3.3 Global Insulin Aspart 30 Injection Revenue by Region: 2020-2031
3.3.1 Global Insulin Aspart 30 Injection Revenue by Region: 2020-2025
3.3.2 Global Insulin Aspart 30 Injection Revenue by Region: 2026-2031
3.4 North America Insulin Aspart 30 Injection Market Facts & Figures by Country
3.4.1 North America Insulin Aspart 30 Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Insulin Aspart 30 Injection Sales by Country (2020-2031)
3.4.3 North America Insulin Aspart 30 Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insulin Aspart 30 Injection Market Facts & Figures by Country
3.5.1 Europe Insulin Aspart 30 Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Insulin Aspart 30 Injection Sales by Country (2020-2031)
3.5.3 Europe Insulin Aspart 30 Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Aspart 30 Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Insulin Aspart 30 Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Insulin Aspart 30 Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Insulin Aspart 30 Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Insulin Aspart 30 Injection Market Facts & Figures by Country
3.7.1 Latin America Insulin Aspart 30 Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Insulin Aspart 30 Injection Sales by Country (2020-2031)
3.7.3 Latin America Insulin Aspart 30 Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Aspart 30 Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Aspart 30 Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Insulin Aspart 30 Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Insulin Aspart 30 Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Aspart 30 Injection Sales by Type (2020-2031)
4.1.1 Global Insulin Aspart 30 Injection Sales by Type (2020-2025)
4.1.2 Global Insulin Aspart 30 Injection Sales by Type (2026-2031)
4.1.3 Global Insulin Aspart 30 Injection Sales Market Share by Type (2020-2031)
4.2 Global Insulin Aspart 30 Injection Revenue by Type (2020-2031)
4.2.1 Global Insulin Aspart 30 Injection Revenue by Type (2020-2025)
4.2.2 Global Insulin Aspart 30 Injection Revenue by Type (2026-2031)
4.2.3 Global Insulin Aspart 30 Injection Revenue Market Share by Type (2020-2031)
4.3 Global Insulin Aspart 30 Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Insulin Aspart 30 Injection Sales by Application (2020-2031)
5.1.1 Global Insulin Aspart 30 Injection Sales by Application (2020-2025)
5.1.2 Global Insulin Aspart 30 Injection Sales by Application (2026-2031)
5.1.3 Global Insulin Aspart 30 Injection Sales Market Share by Application (2020-2031)
5.2 Global Insulin Aspart 30 Injection Revenue by Application (2020-2031)
5.2.1 Global Insulin Aspart 30 Injection Revenue by Application (2020-2025)
5.2.2 Global Insulin Aspart 30 Injection Revenue by Application (2026-2031)
5.2.3 Global Insulin Aspart 30 Injection Revenue Market Share by Application (2020-2031)
5.3 Global Insulin Aspart 30 Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Insulin Aspart 30 Injection Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sihuan Pharmaceutical
6.2.1 Sihuan Pharmaceutical Company Information
6.2.2 Sihuan Pharmaceutical Description and Business Overview
6.2.3 Sihuan Pharmaceutical Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sihuan Pharmaceutical Insulin Aspart 30 Injection Product Portfolio
6.2.5 Sihuan Pharmaceutical Recent Developments/Updates
6.3 Gan and Lee Pharmaceuticals Co., Ltd.
6.3.1 Gan and Lee Pharmaceuticals Co., Ltd. Company Information
6.3.2 Gan and Lee Pharmaceuticals Co., Ltd. Description and Business Overview
6.3.3 Gan and Lee Pharmaceuticals Co., Ltd. Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gan and Lee Pharmaceuticals Co., Ltd. Insulin Aspart 30 Injection Product Portfolio
6.3.5 Gan and Lee Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.4 YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
6.4.1 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Company Information
6.4.2 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Insulin Aspart 30 Injection Product Portfolio
6.4.5 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Tonghua Dongbao Pharmaceutical Co.,Ltd.
6.5.1 Tonghua Dongbao Pharmaceutical Co.,Ltd. Company Information
6.5.2 Tonghua Dongbao Pharmaceutical Co.,Ltd. Description and Business Overview
6.5.3 Tonghua Dongbao Pharmaceutical Co.,Ltd. Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tonghua Dongbao Pharmaceutical Co.,Ltd. Insulin Aspart 30 Injection Product Portfolio
6.5.5 Tonghua Dongbao Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.6 The United Laboratories International Holdings Ltd.
6.6.1 The United Laboratories International Holdings Ltd. Company Information
6.6.2 The United Laboratories International Holdings Ltd. Description and Business Overview
6.6.3 The United Laboratories International Holdings Ltd. Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 The United Laboratories International Holdings Ltd. Insulin Aspart 30 Injection Product Portfolio
6.6.5 The United Laboratories International Holdings Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Aspart 30 Injection Industry Chain Analysis
7.2 Insulin Aspart 30 Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Aspart 30 Injection Production Mode & Process Analysis
7.4 Insulin Aspart 30 Injection Sales and Marketing
7.4.1 Insulin Aspart 30 Injection Sales Channels
7.4.2 Insulin Aspart 30 Injection Distributors
7.5 Insulin Aspart 30 Injection Customer Analysis
8 Insulin Aspart 30 Injection Market Dynamics
8.1 Insulin Aspart 30 Injection Industry Trends
8.2 Insulin Aspart 30 Injection Market Drivers
8.3 Insulin Aspart 30 Injection Market Challenges
8.4 Insulin Aspart 30 Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Insulin Aspart 30 Injection by Type
1.2.1 Global Insulin Aspart 30 Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Insulin Aspart 30 Injection by Application
1.3.1 Global Insulin Aspart 30 Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Insulin Aspart 30 Injection Market Size Estimates and Forecasts
1.4.1 Global Insulin Aspart 30 Injection Revenue 2020-2031
1.4.2 Global Insulin Aspart 30 Injection Sales 2020-2031
1.4.3 Global Insulin Aspart 30 Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Insulin Aspart 30 Injection Market Competition by Manufacturers
2.1 Global Insulin Aspart 30 Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Insulin Aspart 30 Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Insulin Aspart 30 Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Insulin Aspart 30 Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Aspart 30 Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Aspart 30 Injection, Product Type & Application
2.7 Global Key Manufacturers of Insulin Aspart 30 Injection, Date of Enter into This Industry
2.8 Global Insulin Aspart 30 Injection Market Competitive Situation and Trends
2.8.1 Global Insulin Aspart 30 Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Insulin Aspart 30 Injection Players Market Share by Revenue
2.8.3 Global Insulin Aspart 30 Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Aspart 30 Injection Market Scenario by Region
3.1 Global Insulin Aspart 30 Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Insulin Aspart 30 Injection Sales by Region: 2020-2031
3.2.1 Global Insulin Aspart 30 Injection Sales by Region: 2020-2025
3.2.2 Global Insulin Aspart 30 Injection Sales by Region: 2026-2031
3.3 Global Insulin Aspart 30 Injection Revenue by Region: 2020-2031
3.3.1 Global Insulin Aspart 30 Injection Revenue by Region: 2020-2025
3.3.2 Global Insulin Aspart 30 Injection Revenue by Region: 2026-2031
3.4 North America Insulin Aspart 30 Injection Market Facts & Figures by Country
3.4.1 North America Insulin Aspart 30 Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Insulin Aspart 30 Injection Sales by Country (2020-2031)
3.4.3 North America Insulin Aspart 30 Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insulin Aspart 30 Injection Market Facts & Figures by Country
3.5.1 Europe Insulin Aspart 30 Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Insulin Aspart 30 Injection Sales by Country (2020-2031)
3.5.3 Europe Insulin Aspart 30 Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Aspart 30 Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Insulin Aspart 30 Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Insulin Aspart 30 Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Insulin Aspart 30 Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Insulin Aspart 30 Injection Market Facts & Figures by Country
3.7.1 Latin America Insulin Aspart 30 Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Insulin Aspart 30 Injection Sales by Country (2020-2031)
3.7.3 Latin America Insulin Aspart 30 Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Aspart 30 Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Aspart 30 Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Insulin Aspart 30 Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Insulin Aspart 30 Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Aspart 30 Injection Sales by Type (2020-2031)
4.1.1 Global Insulin Aspart 30 Injection Sales by Type (2020-2025)
4.1.2 Global Insulin Aspart 30 Injection Sales by Type (2026-2031)
4.1.3 Global Insulin Aspart 30 Injection Sales Market Share by Type (2020-2031)
4.2 Global Insulin Aspart 30 Injection Revenue by Type (2020-2031)
4.2.1 Global Insulin Aspart 30 Injection Revenue by Type (2020-2025)
4.2.2 Global Insulin Aspart 30 Injection Revenue by Type (2026-2031)
4.2.3 Global Insulin Aspart 30 Injection Revenue Market Share by Type (2020-2031)
4.3 Global Insulin Aspart 30 Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Insulin Aspart 30 Injection Sales by Application (2020-2031)
5.1.1 Global Insulin Aspart 30 Injection Sales by Application (2020-2025)
5.1.2 Global Insulin Aspart 30 Injection Sales by Application (2026-2031)
5.1.3 Global Insulin Aspart 30 Injection Sales Market Share by Application (2020-2031)
5.2 Global Insulin Aspart 30 Injection Revenue by Application (2020-2031)
5.2.1 Global Insulin Aspart 30 Injection Revenue by Application (2020-2025)
5.2.2 Global Insulin Aspart 30 Injection Revenue by Application (2026-2031)
5.2.3 Global Insulin Aspart 30 Injection Revenue Market Share by Application (2020-2031)
5.3 Global Insulin Aspart 30 Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Insulin Aspart 30 Injection Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sihuan Pharmaceutical
6.2.1 Sihuan Pharmaceutical Company Information
6.2.2 Sihuan Pharmaceutical Description and Business Overview
6.2.3 Sihuan Pharmaceutical Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sihuan Pharmaceutical Insulin Aspart 30 Injection Product Portfolio
6.2.5 Sihuan Pharmaceutical Recent Developments/Updates
6.3 Gan and Lee Pharmaceuticals Co., Ltd.
6.3.1 Gan and Lee Pharmaceuticals Co., Ltd. Company Information
6.3.2 Gan and Lee Pharmaceuticals Co., Ltd. Description and Business Overview
6.3.3 Gan and Lee Pharmaceuticals Co., Ltd. Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gan and Lee Pharmaceuticals Co., Ltd. Insulin Aspart 30 Injection Product Portfolio
6.3.5 Gan and Lee Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.4 YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
6.4.1 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Company Information
6.4.2 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Insulin Aspart 30 Injection Product Portfolio
6.4.5 YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Tonghua Dongbao Pharmaceutical Co.,Ltd.
6.5.1 Tonghua Dongbao Pharmaceutical Co.,Ltd. Company Information
6.5.2 Tonghua Dongbao Pharmaceutical Co.,Ltd. Description and Business Overview
6.5.3 Tonghua Dongbao Pharmaceutical Co.,Ltd. Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tonghua Dongbao Pharmaceutical Co.,Ltd. Insulin Aspart 30 Injection Product Portfolio
6.5.5 Tonghua Dongbao Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.6 The United Laboratories International Holdings Ltd.
6.6.1 The United Laboratories International Holdings Ltd. Company Information
6.6.2 The United Laboratories International Holdings Ltd. Description and Business Overview
6.6.3 The United Laboratories International Holdings Ltd. Insulin Aspart 30 Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 The United Laboratories International Holdings Ltd. Insulin Aspart 30 Injection Product Portfolio
6.6.5 The United Laboratories International Holdings Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Aspart 30 Injection Industry Chain Analysis
7.2 Insulin Aspart 30 Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Aspart 30 Injection Production Mode & Process Analysis
7.4 Insulin Aspart 30 Injection Sales and Marketing
7.4.1 Insulin Aspart 30 Injection Sales Channels
7.4.2 Insulin Aspart 30 Injection Distributors
7.5 Insulin Aspart 30 Injection Customer Analysis
8 Insulin Aspart 30 Injection Market Dynamics
8.1 Insulin Aspart 30 Injection Industry Trends
8.2 Insulin Aspart 30 Injection Market Drivers
8.3 Insulin Aspart 30 Injection Market Challenges
8.4 Insulin Aspart 30 Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Insulin Aspart 30 Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Insulin Aspart 30 Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Insulin Aspart 30 Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Insulin Aspart 30 Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Insulin Aspart 30 Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Insulin Aspart 30 Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Insulin Aspart 30 Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Insulin Aspart 30 Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Insulin Aspart 30 Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Insulin Aspart 30 Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin Aspart 30 Injection, Product Type & Application
Table 12. Global Key Manufacturers of Insulin Aspart 30 Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Aspart 30 Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Aspart 30 Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Aspart 30 Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Insulin Aspart 30 Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Insulin Aspart 30 Injection Sales Market Share by Region (2020-2025)
Table 19. Global Insulin Aspart 30 Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Insulin Aspart 30 Injection Sales Market Share by Region (2026-2031)
Table 21. Global Insulin Aspart 30 Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Insulin Aspart 30 Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Insulin Aspart 30 Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Insulin Aspart 30 Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Insulin Aspart 30 Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Insulin Aspart 30 Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Insulin Aspart 30 Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Insulin Aspart 30 Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Insulin Aspart 30 Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Insulin Aspart 30 Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Insulin Aspart 30 Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Insulin Aspart 30 Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Insulin Aspart 30 Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Insulin Aspart 30 Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Insulin Aspart 30 Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Insulin Aspart 30 Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Insulin Aspart 30 Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Insulin Aspart 30 Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Insulin Aspart 30 Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Insulin Aspart 30 Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Insulin Aspart 30 Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Insulin Aspart 30 Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Insulin Aspart 30 Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Insulin Aspart 30 Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Insulin Aspart 30 Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Insulin Aspart 30 Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Insulin Aspart 30 Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Insulin Aspart 30 Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Insulin Aspart 30 Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Insulin Aspart 30 Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Insulin Aspart 30 Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Insulin Aspart 30 Injection Sales Market Share by Type (2020-2025)
Table 53. Global Insulin Aspart 30 Injection Sales Market Share by Type (2026-2031)
Table 54. Global Insulin Aspart 30 Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Insulin Aspart 30 Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Insulin Aspart 30 Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Insulin Aspart 30 Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Insulin Aspart 30 Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Insulin Aspart 30 Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Insulin Aspart 30 Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Insulin Aspart 30 Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Insulin Aspart 30 Injection Sales Market Share by Application (2020-2025)
Table 63. Global Insulin Aspart 30 Injection Sales Market Share by Application (2026-2031)
Table 64. Global Insulin Aspart 30 Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Insulin Aspart 30 Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Insulin Aspart 30 Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Insulin Aspart 30 Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Insulin Aspart 30 Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Insulin Aspart 30 Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novo Nordisk Insulin Aspart 30 Injection Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sihuan Pharmaceutical Company Information
Table 76. Sihuan Pharmaceutical Description and Business Overview
Table 77. Sihuan Pharmaceutical Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sihuan Pharmaceutical Insulin Aspart 30 Injection Product
Table 79. Sihuan Pharmaceutical Recent Developments/Updates
Table 80. Gan and Lee Pharmaceuticals Co., Ltd. Company Information
Table 81. Gan and Lee Pharmaceuticals Co., Ltd. Description and Business Overview
Table 82. Gan and Lee Pharmaceuticals Co., Ltd. Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Gan and Lee Pharmaceuticals Co., Ltd. Insulin Aspart 30 Injection Product
Table 84. Gan and Lee Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 85. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Company Information
Table 86. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Insulin Aspart 30 Injection Product
Table 89. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Tonghua Dongbao Pharmaceutical Co.,Ltd. Company Information
Table 91. Tonghua Dongbao Pharmaceutical Co.,Ltd. Description and Business Overview
Table 92. Tonghua Dongbao Pharmaceutical Co.,Ltd. Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Tonghua Dongbao Pharmaceutical Co.,Ltd. Insulin Aspart 30 Injection Product
Table 94. Tonghua Dongbao Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 95. The United Laboratories International Holdings Ltd. Company Information
Table 96. The United Laboratories International Holdings Ltd. Description and Business Overview
Table 97. The United Laboratories International Holdings Ltd. Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. The United Laboratories International Holdings Ltd. Insulin Aspart 30 Injection Product
Table 99. The United Laboratories International Holdings Ltd. Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Insulin Aspart 30 Injection Distributors List
Table 103. Insulin Aspart 30 Injection Customers List
Table 104. Insulin Aspart 30 Injection Market Trends
Table 105. Insulin Aspart 30 Injection Market Drivers
Table 106. Insulin Aspart 30 Injection Market Challenges
Table 107. Insulin Aspart 30 Injection Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Insulin Aspart 30 Injection
Figure 2. Global Insulin Aspart 30 Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Insulin Aspart 30 Injection Market Share by Type: 2024 & 2031
Figure 4. Original Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Insulin Aspart 30 Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Insulin Aspart 30 Injection Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Insulin Aspart 30 Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Insulin Aspart 30 Injection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Insulin Aspart 30 Injection Sales (2020-2031) & (K Units)
Figure 14. Global Insulin Aspart 30 Injection Average Price (US$/Unit) & (2020-2031)
Figure 15. Insulin Aspart 30 Injection Report Years Considered
Figure 16. Insulin Aspart 30 Injection Sales Share by Manufacturers in 2024
Figure 17. Global Insulin Aspart 30 Injection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Insulin Aspart 30 Injection Players: Market Share by Revenue in Insulin Aspart 30 Injection in 2024
Figure 19. Insulin Aspart 30 Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Insulin Aspart 30 Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Insulin Aspart 30 Injection Sales Market Share by Country (2020-2031)
Figure 22. North America Insulin Aspart 30 Injection Revenue Market Share by Country (2020-2031)
Figure 23. United States Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Insulin Aspart 30 Injection Sales Market Share by Country (2020-2031)
Figure 26. Europe Insulin Aspart 30 Injection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Insulin Aspart 30 Injection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Insulin Aspart 30 Injection Revenue Market Share by Region (2020-2031)
Figure 34. China Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Insulin Aspart 30 Injection Sales Market Share by Country (2020-2031)
Figure 42. Latin America Insulin Aspart 30 Injection Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Insulin Aspart 30 Injection Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Insulin Aspart 30 Injection Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Insulin Aspart 30 Injection by Type (2020-2031)
Figure 52. Global Revenue Market Share of Insulin Aspart 30 Injection by Type (2020-2031)
Figure 53. Global Insulin Aspart 30 Injection Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Insulin Aspart 30 Injection by Application (2020-2031)
Figure 55. Global Revenue Market Share of Insulin Aspart 30 Injection by Application (2020-2031)
Figure 56. Global Insulin Aspart 30 Injection Price (US$/Unit) by Application (2020-2031)
Figure 57. Insulin Aspart 30 Injection Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Insulin Aspart 30 Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Insulin Aspart 30 Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Insulin Aspart 30 Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Insulin Aspart 30 Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Insulin Aspart 30 Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Insulin Aspart 30 Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Insulin Aspart 30 Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Insulin Aspart 30 Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Insulin Aspart 30 Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Insulin Aspart 30 Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin Aspart 30 Injection, Product Type & Application
Table 12. Global Key Manufacturers of Insulin Aspart 30 Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Aspart 30 Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Aspart 30 Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Aspart 30 Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Insulin Aspart 30 Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Insulin Aspart 30 Injection Sales Market Share by Region (2020-2025)
Table 19. Global Insulin Aspart 30 Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Insulin Aspart 30 Injection Sales Market Share by Region (2026-2031)
Table 21. Global Insulin Aspart 30 Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Insulin Aspart 30 Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Insulin Aspart 30 Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Insulin Aspart 30 Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Insulin Aspart 30 Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Insulin Aspart 30 Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Insulin Aspart 30 Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Insulin Aspart 30 Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Insulin Aspart 30 Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Insulin Aspart 30 Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Insulin Aspart 30 Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Insulin Aspart 30 Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Insulin Aspart 30 Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Insulin Aspart 30 Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Insulin Aspart 30 Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Insulin Aspart 30 Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Insulin Aspart 30 Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Insulin Aspart 30 Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Insulin Aspart 30 Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Insulin Aspart 30 Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Insulin Aspart 30 Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Insulin Aspart 30 Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Insulin Aspart 30 Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Insulin Aspart 30 Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Insulin Aspart 30 Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Insulin Aspart 30 Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Insulin Aspart 30 Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Insulin Aspart 30 Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Insulin Aspart 30 Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Insulin Aspart 30 Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Insulin Aspart 30 Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Insulin Aspart 30 Injection Sales Market Share by Type (2020-2025)
Table 53. Global Insulin Aspart 30 Injection Sales Market Share by Type (2026-2031)
Table 54. Global Insulin Aspart 30 Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Insulin Aspart 30 Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Insulin Aspart 30 Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Insulin Aspart 30 Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Insulin Aspart 30 Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Insulin Aspart 30 Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Insulin Aspart 30 Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Insulin Aspart 30 Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Insulin Aspart 30 Injection Sales Market Share by Application (2020-2025)
Table 63. Global Insulin Aspart 30 Injection Sales Market Share by Application (2026-2031)
Table 64. Global Insulin Aspart 30 Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Insulin Aspart 30 Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Insulin Aspart 30 Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Insulin Aspart 30 Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Insulin Aspart 30 Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Insulin Aspart 30 Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novo Nordisk Insulin Aspart 30 Injection Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sihuan Pharmaceutical Company Information
Table 76. Sihuan Pharmaceutical Description and Business Overview
Table 77. Sihuan Pharmaceutical Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sihuan Pharmaceutical Insulin Aspart 30 Injection Product
Table 79. Sihuan Pharmaceutical Recent Developments/Updates
Table 80. Gan and Lee Pharmaceuticals Co., Ltd. Company Information
Table 81. Gan and Lee Pharmaceuticals Co., Ltd. Description and Business Overview
Table 82. Gan and Lee Pharmaceuticals Co., Ltd. Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Gan and Lee Pharmaceuticals Co., Ltd. Insulin Aspart 30 Injection Product
Table 84. Gan and Lee Pharmaceuticals Co., Ltd. Recent Developments/Updates
Table 85. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Company Information
Table 86. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Insulin Aspart 30 Injection Product
Table 89. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Tonghua Dongbao Pharmaceutical Co.,Ltd. Company Information
Table 91. Tonghua Dongbao Pharmaceutical Co.,Ltd. Description and Business Overview
Table 92. Tonghua Dongbao Pharmaceutical Co.,Ltd. Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Tonghua Dongbao Pharmaceutical Co.,Ltd. Insulin Aspart 30 Injection Product
Table 94. Tonghua Dongbao Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 95. The United Laboratories International Holdings Ltd. Company Information
Table 96. The United Laboratories International Holdings Ltd. Description and Business Overview
Table 97. The United Laboratories International Holdings Ltd. Insulin Aspart 30 Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. The United Laboratories International Holdings Ltd. Insulin Aspart 30 Injection Product
Table 99. The United Laboratories International Holdings Ltd. Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Insulin Aspart 30 Injection Distributors List
Table 103. Insulin Aspart 30 Injection Customers List
Table 104. Insulin Aspart 30 Injection Market Trends
Table 105. Insulin Aspart 30 Injection Market Drivers
Table 106. Insulin Aspart 30 Injection Market Challenges
Table 107. Insulin Aspart 30 Injection Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Insulin Aspart 30 Injection
Figure 2. Global Insulin Aspart 30 Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Insulin Aspart 30 Injection Market Share by Type: 2024 & 2031
Figure 4. Original Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Insulin Aspart 30 Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Insulin Aspart 30 Injection Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Insulin Aspart 30 Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Insulin Aspart 30 Injection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Insulin Aspart 30 Injection Sales (2020-2031) & (K Units)
Figure 14. Global Insulin Aspart 30 Injection Average Price (US$/Unit) & (2020-2031)
Figure 15. Insulin Aspart 30 Injection Report Years Considered
Figure 16. Insulin Aspart 30 Injection Sales Share by Manufacturers in 2024
Figure 17. Global Insulin Aspart 30 Injection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Insulin Aspart 30 Injection Players: Market Share by Revenue in Insulin Aspart 30 Injection in 2024
Figure 19. Insulin Aspart 30 Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Insulin Aspart 30 Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Insulin Aspart 30 Injection Sales Market Share by Country (2020-2031)
Figure 22. North America Insulin Aspart 30 Injection Revenue Market Share by Country (2020-2031)
Figure 23. United States Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Insulin Aspart 30 Injection Sales Market Share by Country (2020-2031)
Figure 26. Europe Insulin Aspart 30 Injection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Insulin Aspart 30 Injection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Insulin Aspart 30 Injection Revenue Market Share by Region (2020-2031)
Figure 34. China Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Insulin Aspart 30 Injection Sales Market Share by Country (2020-2031)
Figure 42. Latin America Insulin Aspart 30 Injection Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Insulin Aspart 30 Injection Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Insulin Aspart 30 Injection Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Insulin Aspart 30 Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Insulin Aspart 30 Injection by Type (2020-2031)
Figure 52. Global Revenue Market Share of Insulin Aspart 30 Injection by Type (2020-2031)
Figure 53. Global Insulin Aspart 30 Injection Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Insulin Aspart 30 Injection by Application (2020-2031)
Figure 55. Global Revenue Market Share of Insulin Aspart 30 Injection by Application (2020-2031)
Figure 56. Global Insulin Aspart 30 Injection Price (US$/Unit) by Application (2020-2031)
Figure 57. Insulin Aspart 30 Injection Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232